Article Versions Notes

Buciuman CA, Dobrea CM, Butuca A, Frum A, Gligor FG, Botea MO, Vicaș LG, Mureșan ME, Gligor O, Maghiar F, et al. Pharmacovigilance Insights into Ibuprofen’s Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports. Pharmaceuticals. 2025; 18(9):1301. https://doi.org/10.3390/ph18091301

Buciuman, Cristina Anamaria, Carmen Maximiliana Dobrea, Anca Butuca, Adina Frum, Felicia Gabriela Gligor, Mihai O. Botea, Laura Grațiela Vicaș, Mariana Eugenia Mureșan, Octavia Gligor, Florin Maghiar, and et al. 2025. "Pharmacovigilance Insights into Ibuprofen’s Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports" Pharmaceuticals 18, no. 9: 1301. https://doi.org/10.3390/ph18091301

Buciuman, C. A., Dobrea, C. M., Butuca, A., Frum, A., Gligor, F. G., Botea, M. O., Vicaș, L. G., Mureșan, M. E., Gligor, O., Maghiar, F., Manole, A., & Morgovan, C. (2025). Pharmacovigilance Insights into Ibuprofen’s Neuropsychiatric Safety: A Retrospective Analysis of EudraVigilance Reports. Pharmaceuticals, 18(9), 1301. https://doi.org/10.3390/ph18091301